Literature DB >> 35718422

Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Sherry-Ann Brown1, Eric H Yang2, Mary Branch3, Craig Beavers4, Anne Blaes5, Michael G Fradley6, Richard K Cheng7.   

Abstract

Cardiovascular disease is a leading cause of death in cancer survivors, after recurrence of the primary tumor or occurrence of a secondary malignancy. Consequently, the interdisciplinary field of cardio-oncology has grown rapidly in recent years to address the cardiovascular care needs of this unique population through clinical care and research initiatives. Here, the authors discuss the ideal infrastructure for training and career development in cardio-oncology translational and implementation science and emphasize the importance of the multidisciplinary cardiovascular team for both research and patient care. Cardio-oncology training opportunities in general cardiology, hematology/oncology, and specialized cardio-oncology clinical and research fellowships are also considered.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardio-oncology; Cardiology; Education; Oncology; Trainees

Mesh:

Year:  2022        PMID: 35718422      PMCID: PMC9236555          DOI: 10.1016/j.hfc.2022.02.014

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   2.828


  50 in total

Review 1.  Role of biomarkers in chemotherapy-induced cardiotoxicity.

Authors:  Daniela Cardinale; Maria Teresa Sandri
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

2.  Is it time to include cancer in cardiovascular risk prediction tools?

Authors:  Anne H Blaes; Chetan Shenoy
Journal:  Lancet       Date:  2019-08-20       Impact factor: 79.321

3.  Case Reports in the Age of Twitter.

Authors:  Adam S Cifu; Andrae L Vandross; Vinay Prasad
Journal:  Am J Med       Date:  2019-04-15       Impact factor: 4.965

Review 4.  Cardiovascular Toxic Effects of Targeted Cancer Therapies.

Authors:  Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

Review 5.  Cardio-Oncology Education and Training: JACC Council Perspectives.

Authors:  Jose A Alvarez-Cardona; Jordan Ray; Joseph Carver; Vlad Zaha; Richard Cheng; Eric Yang; Joshua D Mitchell; Keith Stockerl-Goldstein; Lavanya Kondapalli; Susan Dent; Anita Arnold; Sherry Ann Brown; Monica Leja; Ana Barac; Daniel J Lenihan; Joerg Herrmann
Journal:  J Am Coll Cardiol       Date:  2020-11-10       Impact factor: 24.094

6.  Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Saro H Armenian; Christina Lacchetti; Ana Barac; Joseph Carver; Louis S Constine; Neelima Denduluri; Susan Dent; Pamela S Douglas; Jean-Bernard Durand; Michael Ewer; Carol Fabian; Melissa Hudson; Mariell Jessup; Lee W Jones; Bonnie Ky; Erica L Mayer; Javid Moslehi; Kevin Oeffinger; Katharine Ray; Kathryn Ruddy; Daniel Lenihan
Journal:  J Clin Oncol       Date:  2016-12-05       Impact factor: 44.544

7.  Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.

Authors:  Eugene Suh; Kayla L Stratton; Wendy M Leisenring; Paul C Nathan; Jennifer S Ford; David R Freyer; Jennifer L McNeer; Wendy Stock; Marilyn Stovall; Kevin R Krull; Charles A Sklar; Joseph P Neglia; Gregory T Armstrong; Kevin C Oeffinger; Leslie L Robison; Tara O Henderson
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316

8.  Cardiovascular Disease Mortality Among Breast Cancer Survivors.

Authors:  Patrick T Bradshaw; June Stevens; Nikhil Khankari; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Epidemiology       Date:  2016-01       Impact factor: 4.822

9.  A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic.

Authors:  Sherry-Ann Brown; Sahishnu Patel; David Rayan; Svetlana Zaharova; Mingqian Lin; Tarek Nafee; Bipin Sunkara; Ragasnehith Maddula; James MacLeod; Krishna Doshi; Joshua Meskin; David Marks; Jorge Saucedo
Journal:  Cardiooncology       Date:  2021-01-13

10.  Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.

Authors:  Udo Hoffmann; Tomas G Neilan; Zsofia D Drobni; Raza M Alvi; Jana Taron; Amna Zafar; Sean P Murphy; Paula K Rambarat; Rayma C Mosarla; Charlotte Lee; Daniel A Zlotoff; Vineet K Raghu; Sarah E Hartmann; Hannah K Gilman; Jingyi Gong; Leyre Zubiri; Ryan J Sullivan; Kerry L Reynolds; Thomas Mayrhofer; Lili Zhang
Journal:  Circulation       Date:  2020-10-02       Impact factor: 29.690

View more
  1 in total

1.  Cardio-oncology and COVID 19: Lessons learned, past reflections and future deliberations.

Authors:  Sherry-Ann Brown
Journal:  Am Heart J Plus       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.